Eclipse Topical Analgesic

Manufacturer
Sambria Pharmaceuticals, Inc. | A.I.G. Technologies, Inc. | JP Packaging LLC
Effective date
2018-08-06
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:02:23

Label at a glance#

ProductEclipse Topical Analgesic FA
Active ingredientBENZOCAINE
Label structure11 sections

Indications and uses

For temporary relief of pain and itching due to minor skin irritation.

Dosage and administration

For adults and children two-years or older: Apply to affected area not more then 3 or 4 times daily.  Children under 2 years of age: consult a physician.

Label contents#

Full prescribing information#

​Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Benzocaine     20.0% w/w

​Purpose

OTC - PURPOSE SECTION

External Analgesic

​Uses

INDICATIONS & USAGE SECTION

For temporary relief of pain and itching due to minor skin irritation.

​Warnings

WARNINGS SECTION

​For external use only

Avoid contact with eyes

OTC - STOP USE SECTION

​Stop use and ask doctor if​

• Condition worsens, or if symptoms persist for more then 7 days or clear up and occur again within a few days.  Discontinue use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

​Keep out of reach of children​

• If product is swallowed, get medical help or contact a Poison Control Center right away.

​Directions

DOSAGE & ADMINISTRATION SECTION

For adults and children two-years or older: Apply to affected area not more then 3 or 4 times daily.  Children under 2 years of age: consult a physician.

​Inactive Ingredients

INACTIVE INGREDIENT SECTION

Aqua (Deionized Water), Arnica Montana Flower Extract, C13-14 Isoparaffin, Caprylic/Capric Triglyceride, Cetearetj-25, Chondroitin Sulfate, Diethylhexyl Sodium Sulfosuccinate, Emu Oil, Ethoxydiglycol, Ethylhexylglycerin, Glucosamine Sulfate, Glycerin, Isopropyl Palmitate, Laureth-7, Melaleuca alternifolia (Tea Tree) Leaf Oil, Methylfulfonylmenthane (MSM), Phenoxyethanol, Polyacrylamide, Polysorbate-20, Safflower Oil, Stearic Acid, Triethanolamine

​Other Information

OTHER SAFETY INFORMATION

Protect this product from excessive heat or direct sun.

​Questions or Comments?

OTC - QUESTIONS SECTION

FDA Registered: NDC No. 54723-667-08

800-759-6876

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

packetpacket

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
723562benzocaine 20 % Topical CreamPSN2
723562benzocaine 200 MG/ML Topical CreamSCD2
723562benzocaine 20 % Topical CreamSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
54723-668-082021-07-23C16284748780-1c7ccaba7-12d2-fd44-e053-dadaa90aa01bEclipse FA Topical Analgesic

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54723-668-08Eclipse Topical AnalgesicFA1500 mg in 1 PACKETCREAM15002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54723-668ECLIPSE TOPICAL ANALGESIC FA (BENZOCAINE) CREAM [SAMBRIA PHARMACEUTICALS, INC.]2Legacy NDC, 1 package rows20191227_b03f91cd-9da2-4cbe-ad12-c98c1fe07641.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54723-66854723-668-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3bd75180-1c67-4c4f-9cd5-fa2581cb30fdb03f91cd-9da2-4cbe-ad12-c98c1fe076412018-08-06WarningsExact identifier
spl id: 3bd75180-1c67-4c4f-9cd5-fa2581cb30fd
spl set id: b03f91cd-9da2-4cbe-ad12-c98c1fe07641

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.